InsidersTradesSigma
Follow the 씨젠 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 씨젠 has logged 59 public disclosures. Market capitalisation: €1,464.9bn. The latest transaction was filed on 29 April 2026 (Purchase). Among the most active insiders: 최대엽. All data is openly available.
58
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
50 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 씨젠 Strong Buy (bullish), based on 2 analysts. Average price target: ₩45,500.
Fundamental score
Ranked 8,011 of 29,063 companies
62.7
score / 100
Value59
Quality67
FCF yld7.4%
Earn yld3.3%
EV/EBITDA12.2x
ROE6.5%
Gross mgn64%
Net mgn10%
Debt/EBITDA1.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 29 April 2026
Declarations59 total
Other
25 of 59 declarations
Acerca de 씨젠
씨젠 es una empresa del sector de la salud y farmacéutico, que cotiza en la bolsa XKRX. Se centra en el desarrollo de soluciones de diagnóstico molecular.